Susquehanna International Group, LLP Seelos Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$0.16 - $1.64 $4,320 - $44,280	-27,000 Reduced 60.4%	17,700 $3,000
Q2 2023 Aug 11, 2023	SELL	$0.66 - $1.22 $792 - $1,464	-1,200 Reduced 2.61%	44,700 $53,000
Q1 2023 May 16, 2023	SELL	$0.59 - $1.04 $79,178 - $139,568	-134,200 Reduced 74.51%	45,900 $31,000
Q4 2022 Feb 14, 2023	BUY	$0.66 - $259.46 $32,076 - $12.6 Million	48,600 Added 36.96%	180,100 $122,000
Q3 2022 Nov 14, 2022	BUY	$0.65 - $278.68 $51,740 - $22.2 Million	79,600 Added 153.37%	131,500 $135,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.